Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
Frontiers in Medicine|July 29, 2020
Association of Tumor Budding With Immune Evasion Pathways in Primary Colorectal Cancer and Patient-Derived XenograftsSilvia Guil-Luna, Rafael Mena, Carmen Navarrete-Sirvent, et al.
Cancers|September 9, 2023
Ibero-American Consensus Review and Incorporation of New Biomarkers for Clinical Practice in Colorectal CancerCarlos Eduardo Bonilla, Paola Montenegro, Juan Manuel O'Connor, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2017
First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD)Alfredo Carrato, Albert Abad, Bartomeu Massuti, et al.
BMC Biology|January 14, 2018
A role for endothelial nitric oxide synthase in intestinal stem cell proliferation and mesenchymal colorectal cancerJon Peñarando, Laura M López-Sánchez, Rafael Mena, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2023
Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trialsAlessandra Raimondi, Federico Nichetti, Arndt Stahler, et al.
Targeted Oncology|December 16, 2017
Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer PatientsMaria Alsina, Fernando Rivera, Francisco Javier Ramos, et al.
Plos One|November 24, 2012
Role of Kras status in patients with metastatic colorectal cancer receiving first-line chemotherapy plus bevacizumab: a TTD group cooperative studyEduardo Díaz-Rubio, Auxiliadora Gómez-España, Bartomeu Massutí, et al.
Targeted Oncology|November 13, 2017
A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer PatientsMaria Alsina, Fernando Rivera, Francisco Javier Ramos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 26, 2011
Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinomaCarlos Gómez-Martín, Angel Concha, José María Corominas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 14, 2005
A panel discussion of controversies and challenges in the adjuvant treatment of colon cancerEduardo Díaz-Rubio García, Albert Abad Esteve, Antonio Antón Torres, et al.
Pageof 15